Invitae Corporation
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Invitae Corporation - overview
Established
2012
Location
San Francisco, CA, US
Primary Industry
Biotechnology
About
Founded in 2012 and based in the US, Invitae Corporation is a medical genetics company that operates as a genetic information company in the diagnostic and research industry. Invitae Corporation MRD tests include multiple genes associated with hereditary cancer, neurological disorders, cardiovascular disorders, pediatric disorders, metabolic disorders, and other hereditary conditions. January 2021, Invitae Corporation announced a new project with Bristol Myers Squibb, Janssen Research & Development, LLC (Janssen), Novartis, and Genentech to standardize how MRD data is generated and assessed in clinical trials.
Current Investors
Perceptive Advisors, Thomas, McNerney & Partners, SB Management
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Bioinformatics, Diagnostic, Medical & Imaging Laboratories, Healthcare IT
Website
www.invitae.com
Verticals
HealthTech
Company Stage
Mature
Total Amount Raised
Subscriber access only
Invitae Corporation - timeline of key events
Invitae Corporation - financials
| Fiscal Year Ended | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 1,604,000 | 8,378,000 | 25,048,000 | 68,221,000 | 147,699,000 | 216,824,000 | - | - | - |
| % Revenue Growth (YoY) | - | 422.3% | 199.0% | 172.4% | 116.5% | 46.8% | - | - | - |
| EBITDA (USD) | (45,037,000) | (83,524,000) | (93,319,000) | (111,962,000) | (109,017,000) | (223,490,000) | - | - | - |
| Operating Income (USD) | (47,352,000) | (89,477,000) | (100,183,000) | (121,279,000) | (122,557,000) | (244,112,000) | - | - | - |
| Operating Margin | (2952.1%) | (1068.0%) | (400.0%) | (177.8%) | (83.0%) | (112.6%) | - | - | - |
| % EBITDA Margin | (2807.8%) | (996.9%) | (372.6%) | (164.1%) | (73.8%) | (103.1%) | - | - | - |
| NET Income (USD) | (47,492,000) | (89,782,000) | (100,256,000) | (123,380,000) | (129,355,000) | (241,965,000) | - | - | - |
| % Net Margin | (2960.8%) | (1071.6%) | (400.3%) | (180.9%) | (87.6%) | (111.6%) | - | - | - |
Invitae Corporation - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Bankruptcy/Write-off | Completed | Invitae Corporation | - |
Displaying 1 - 1 of 1
Invitae Corporation - employee data
Invitae Corporation - key contacts
| Name | Position | Start Date | End Date | Vcard | Bio | ||
|---|---|---|---|---|---|---|---|
| President and member of Board of Directors | BM | ||||||
| Director Board Of Directors | BM |
BM Board Member
Want to see more?
Request a demo for full access to this profile
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.